| |
| Names | |
|---|---|
| IUPAC name 4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-benzocycloheptathiophen-10-ol | |
| Other names 10-hydroxy-ketotifen, WR621365 | |
| Identifiers | |
| CAS Number | |
| 3D model (JSmol) | |
| PubChem CID | |
SMILES
| |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references | |
10-Hydroxyketotifen (WR621365) is a biologically inactive metabolite of ketotifen. Despite the mainstream scientific consensus that 10-hydroxyketotifen is a biologically inactive compound, its pharmacological properties are not very well studied outside the context of ketotifen, therefore, 10-hydroxyketotifen may still possess biological activity similarly to norketotifen, another metabolite of ketotifen.
Metabolic role
Main article: KetotifenKetotifen is an antihistamine medication which metabolizes to several compounds, including 10-hydroxyketotifen. Ketotifen, like other antihistamines, is mainly metabolized by the cytochrome P450 (CYP) enzymes, especially CYP3A4 in the liver. The CYP enzymes are responsible for the oxidation and demethylation of ketotifen, producing the major metabolites norketotifen and 10-hydroxyketotifen. Norketotifen is pharmacologically active and has a similar potency as ketotifen, while 10-hydroxyketotifen is inactive. The metabolites are then conjugated with glucuronic acid or sulfate and excreted in the urine and feces.
The definition and measurement of biological activity of drugs can be complex: biological activity is often defined in terms of the ability of a molecule to effect a change in a biological process, which can be quantified and measured in various ways; as such, even if 10-hydroxyketotifen is currently deemed inactive, it is possible that under certain conditions or within specific biological assays, some level of activity might be observed.
References
- ^ Milner E, Sousa J, Pybus B, Auschwitz J, Caridha D, Gardner S, et al. (2012). "Ketotifen is an antimalarial prodrug of norketotifen with blood schizonticidal and liver-stage efficacy". European Journal of Drug Metabolism and Pharmacokinetics. 37 (1): 17–22. doi:10.1007/s13318-012-0080-2. PMID 22314893.
- Gunnar AK, Wright GE, Chen JL, Maioli, AT (July 3, 2002). "European Patent: optically active isomers of ketotifen and therapeutically active metabolites thereof". Archived from the original on May 2, 2024. Retrieved May 2, 2024.
- Julien-Larose C, Guerret M, Lavene D, Kiechel JR (1983). "Quantification of ketotifen and its metabolites in human plasma by gas chromatography mass spectrometry". Biological Mass Spectrometry. 10 (3): 136–142. doi:10.1002/bms.1200100307. PMID 6850066.
- Bersier PM, Szczepaniak W, Ren M (1992). "Direct Differential Pulse Polarographic and Adsorptive Stripping Voltammetric Assay of Ketotifen in Tablets". Archiv der Pharmazie. 325 (5): 253–259. doi:10.1002/ardp.19923250502.
- Li L, Liu R, Peng C, Chen X, Li J (July 2022). "Pharmacogenomics for the efficacy and side effects of antihistamines". Exp Dermatol. 31 (7): 993–1004. doi:10.1111/exd.14602. PMID 35538735.
- Merk HF (November 2001). "Standard treatment: the role of antihistamines". J Investig Dermatol Symp Proc. 6 (2): 153–6. doi:10.1046/j.0022-202x.2001.00032.x. PMID 11764306.
- El-Kommos ME, El-Gizawy SM, Atia NN, Hosny NM (2015). "Analysis for commonly prescribed non-sedating antihistamines". Analytical Chemistry Research. 3: 1–12. doi:10.1016/j.ancr.2014.11.003.
- Jáuregui I, Mullol J, Bartra J, del Cuvillo A, Dávila I, Montoro J, et al. (2006). "H1 antihistamines: psychomotor performance and driving". J Investig Allergol Clin Immunol. 16 (Suppl 1): 37–44. PMID 17357376.
- Lieberman P, Hernandez-Trujillo V, Lieberman J, Frew AJ (2008). "Antihistamines". Clinical Immunology. pp. 1317–1329. doi:10.1016/B978-0-323-04404-2.10089-2. ISBN 978-0-323-04404-2. Archived from the original on February 24, 2024. Retrieved February 14, 2024.
- "Center for drug evaluation and research. Application no. 21-066" (PDF). Archived (PDF) from the original on February 14, 2024. Retrieved February 14, 2024.
- Jackson CM, Esnouf MP, Winzor DJ, Duewer DL (March 16, 2007). "Defining and measuring biological activity: Applying the principles of metrology". Accreditation and Quality Assurance. 12 (6): 283–294. doi:10.1007/s00769-006-0254-1.
